The Psoriatic Nonlesional Skin: A Battlefield between Susceptibility and Protective Factors

J Invest Dermatol. 2021 Dec;141(12):2785-2790. doi: 10.1016/j.jid.2021.05.020. Epub 2021 Jul 1.

Abstract

In the last two decades, large-scale gene-expression studies on psoriatic skin samples revealed that even though nonlesional skin is macroscopically identical to healthy skin, it harbors several molecular differences. Originally, these molecular differences were thought to represent susceptibility factors for plaque formation. However, we review in this paper the several factors of immune regulation and structural alteration that are specific for the nonlesional skin and serve as protective factors by counteracting plaque formation and contributing to the maintenance of the nonlesional phenotype.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Disease Susceptibility
  • Humans
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / blood
  • Psoriasis / etiology
  • Psoriasis / immunology*
  • Psoriasis / pathology
  • Skin / immunology*
  • Skin / pathology

Substances

  • Interleukin-1beta